
Careers
At SpeeDx, we're transforming how the world detects pathogens and guides treatment. Join a global team of scientists, innovators, and commercial professionals who are passionate about improving patient outcomes through cutting-edge molecular diagnostics. If you're looking for meaningful work where your contributions make a real-world impact, SpeeDx is where you belong.
Join the Future of Molecular Innovation
Passion-Driven Innovation

Work That Matters
At SpeeDx, we are passionate about making a difference and every role contributes. Whether you're developing new technologies in our R&D labs, manufacturing products that reach patients worldwide, or building partnerships that expand global access — your work has purpose.

Real Impact
At SpeeDx, we are passionate about making a difference and every role contributes. Whether you're developing new technologies in our R&D labs, manufacturing products that reach patients worldwide, or building partnerships that expand global access — your work has purpose.

Real Impact
Our diagnostic products are used in laboratories across 100+ countries
-
Millions of patient samples processed annually
-
Global clinical guidelines influenced by our research and product development [1-6]
-
Cure rates transformed through Resistance Guided Therapy [7,8]

Work That Matters
At SpeeDx, we are passionate about making a difference and every role contributes. Whether you're developing new technologies in our R&D labs, manufacturing products that reach patients worldwide, or building partnerships that expand global access — your work has purpose.
Passion-Driven Innovation

Work That Matters
At SpeeDx, we are passionate about making a difference and every role contributes. Whether you're developing new technologies in our R&D labs, manufacturing products that reach patients worldwide, or building partnerships that expand global access — your work has purpose.

Real Impact
Our diagnostic products are used in laboratories across 100+ countries
-
Millions of patient samples processed annually
-
Global clinical guidelines influenced by our research and product development [1-6]
-
Cure rates transformed through Resistance Guided Therapy [7,8]
Where Breakthrough Ideas Become Reality

Our innovations
-
PlexPlus® technology (doubles PCR output)
-
InSignia® viability testing
-
ResistancePlus® (enabling resistance-guided therapy [7,8])
-
100+ patents filed and granted
We encourage...
-
Curiosity and scientific exploration
-
Cross-functional collaboration
-
Calculated risk-taking
-
Continuous learning and development
-
Open communication at all levels
Innovation Culture:

We invest in your professional growth through ongoing training and development programs, conference attendance and networking opportunities, and support for advanced degree pursuits. Our leadership development initiatives help you build the skills needed for advancement, while our culture of internal mobility encourages cross-functional moves and promotions as your career evolves.
Grow Your Skills,
Advance Your Career
Global Impact, Local Teams
SpeeDx Presence:
-
Sydney, Australia (Headquarters)
-
Austin, Texas, USA (US Office)
-
London, United Kingdom (European Office)

Contact the team
Find out about SpeeDx open positions
References:
-
CDC - https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm
-
BASHH - https://www.bashh.org/resources/19/mycoplasma_genitalium_2018/
-
Australian STI treatment guidelines - https://sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium/
-
Europe (IUSTI) - https://pubmed.ncbi.nlm.nih.gov/35182080/
-
France (HAS) - https://has-sante.fr/jcms/p_3604652/fr/traitement-curatif-des-personnes-infectees-par-mycoplasma-genitalium
-
Korea (KDCA) - https://pmc.ncbi.nlm.nih.gov/articles/PMC10789542/
-
Durukan et. al. Clin Infect Dis. 2020 Sep 12;71(6):1461-1468
-
Read et. al. Clin Infect Dis. 2019 Feb 1;68(4):554-560
Footnotes:
*ResistancePlus® products are not available in all regions. For options within your region please reach out to our team today.
References:
1. CDC - https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm
2. BASHH - https://www.bashh.org/resources/19/mycoplasma_genitalium_2018/
3. Australian STI treatment guidelines - https://sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium/
4. Europe (IUSTI) - https://pubmed.ncbi.nlm.nih.gov/35182080/
5. France (HAS) - https://www.has-sante.fr/jcms/p_3604652/fr/traitement-curatif-des-personnes-infectees-par-mycoplasma-genitalium
